Literature DB >> 18685918

Advances in the use of IVIg in neurological disorders.

Richard Hughes1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18685918     DOI: 10.1007/s00415-008-3001-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  4 in total

1.  European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.

Authors:  R A C Hughes; P Bouche; D R Cornblath; E Evers; R D M Hadden; A Hahn; I Illa; C L Koski; J M Léger; E Nobile-Orazio; J Pollard; C Sommer; P Van den Bergh; P A van Doorn; I N van Schaik
Journal:  Eur J Neurol       Date:  2006-04       Impact factor: 6.089

2.  Guidelines on the use of intravenous immune globulin for neurologic conditions.

Authors:  Tom Feasby; Brenda Banwell; Timothy Benstead; Vera Bril; Melissa Brouwers; Mark Freedman; Angelika Hahn; Heather Hume; John Freedman; David Pi; Louis Wadsworth
Journal:  Transfus Med Rev       Date:  2007-04

3.  Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.

Authors:  Richard A C Hughes; Peter Donofrio; Vera Bril; Marinos C Dalakas; Chunqin Deng; Kim Hanna; Hans-Peter Hartung; Norman Latov; Ingemar S J Merkies; Pieter A van Doorn
Journal:  Lancet Neurol       Date:  2008-02       Impact factor: 44.182

Review 4.  Intravenous immunoglobulin for multifocal motor neuropathy.

Authors:  I N van Schaik; L H van den Berg; R de Haan; M Vermeulen
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18
  4 in total
  1 in total

1.  Intravenous immunoglobulin in pediatrics: A review.

Authors:  A N Prasad; Sanjay Chaudhary
Journal:  Med J Armed Forces India       Date:  2013-08-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.